| Wed, Nov 18, 2009 |
| • |
Vaccines on horizon for AIDS, Alzheimer's, herpes
AP (Wed, Nov 18)
|
| Tue, Nov 17, 2009 |
| • |
Vaccines on horizon for AIDS, Alzheimer's, herpes
AP (Tue, Nov 17)
|
| Mon, Nov 16, 2009 |
| • |
Crucell launches global brand to reflect and reinforce its leading position in healthcare innovation
Marketwire (Mon, Nov 16)
|
| Wed, Nov 11, 2009 |
| • |
The Complete List of Dutch ADR Stocks
at Seeking Alpha (Wed, Nov 11)
|
| Thu, Nov 5, 2009 |
| • |
TapImmune Signs License Agreement With Crucell N.V.
GlobeNewswire (Thu, Nov 5)
|
| • |
Crucell N.V. upgraded by UBS
Briefing.com (Thu, Nov 5)
|
| Tue, Nov 3, 2009 |
| • |
Johnson & Johnson to cut up to 8,200 jobs
at MarketWatch (Tue, Nov 3)
|
| • |
Crucell 3Q profit falls 22 percent
AP (Tue, Nov 3)
|
| • |
Crucell Earnings Presentation Call scheduled for 8:00 am ET today
CCBN (Tue, Nov 3)
|
| • |
Q3 2009 Crucell Earnings Release - 01:45 am ET
CCBN (Tue, Nov 3)
|
| • |
Calmune and Crucell Enter Exclusive Research Collaboration
Marketwire (Tue, Nov 3)
|
| • |
UPDATE - Crucell Q3 profit falls 22 pct, keeps outlook
at Reuters (Tue, Nov 3)
|
| • |
Crucell Announces Third Quarter 2009 Results
Marketwire (Tue, Nov 3)
|
| Wed, Oct 28, 2009 |
| • |
2 Stocks Hitting Low Notes
at Motley Fool (Wed, Oct 28)
|
| Tue, Oct 27, 2009 |
| • |
Crucell to Release Q3 2009 Results on Tuesday November 3, 2009
Marketwire (Tue, Oct 27)
|
| Wed, Oct 21, 2009 |
| • |
Crucell HIV Vaccine: Promising Preliminary Results Phase I Study Presented by Dr Dan Barouch at AIDS Vaccine 2009 in Paris
Marketwire (Wed, Oct 21)
|
| Tue, Oct 20, 2009 |
| • |
Crucell Rabies Monoclonal Antibody Combination: Positive Results Philippines Phase II Study Presented at RITA Conference
Marketwire (Tue, Oct 20)
|
| Fri, Oct 16, 2009 |
| • |
Baxter Beats Again -- the Streak Is Alive!
at Motley Fool (Fri, Oct 16)
|
| Tue, Oct 13, 2009 |
| • |
J&J Needs to Get Drugged Up
at Motley Fool (Tue, Oct 13)
|
| • |
[$$] J&J Is Still OK
at Barrons.com (Tue, Oct 13)
|
| Older Headlines |
|
|
|
|
Help
0.10 (0.46%) 
Headlines
